ARGENX SE (ARGX) — Earnings Call Analysis & IR Page

ARGENX SE is a Healthcare company operating in Biotechnology with a $61.25B market cap.

Most recent earnings call: Q4 FY25 on Feb 26, 2026.

19 earnings calls indexed on Spoken Alpha.

Behavioral analysis

Management language signature

Disclosures

Investor Relations

Confidence: 0.61

argenx.com/investors

Extracted from Unknown source, 2026-08-30.

Transcripts

Recent earnings calls

Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.

All 19 calls

History

Earnings history

Reported quarters with consensus, surprise, and 1-day reaction context.

No earnings history available.

Peers

Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.

API

For developers and AI agents

The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for ARGX.

$ curl https://api.spokenalpha.com/v1/companies/ARGX

Get an API key API docs

FAQ

Frequently asked about ARGX

Where can I find ARGENX SE's (ARGX) earnings call transcripts?

Spoken Alpha indexes ARGX's earnings call transcripts at https://spokenalpha.com/companies/ARGX. Each call links to attributed speakers and parsed analyst Q&A.

When was ARGENX SE's most recent earnings call?

ARGENX SE (ARGX) held its most recent earnings call on 2026-02-26, covering fiscal Q4 2025.

What sector is ARGX in?

ARGENX SE (ARGX) operates in the Healthcare sector (Biotechnology industry).

Overview